Technology Can-Fite Announces ADS Ratio Change AIT News Desk Jan 2, 2023 Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver…
Healthcare Management Following Complete Clearance Of Cancer Lesions In Advanced Liver Cancer Patient, Can-Fite Is Filing… AIT News Desk Dec 29, 2021 Namodenoson Headed into Pivotal Phase III Liver Cancer Study Can-Fite BioPharma Ltd, a biotechnology company advancing a pipeline of proprietary…